21st Century Oncology to price initial public common stock offering

Morgan Stanley, JPMorgan and Wells Fargo are joint bookrunners

By Devika Patel

Knoxville, Tenn., Feb. 11 - 21st Century Oncology Holdings, Inc. said it will price an initial public offering of common stock.

Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC and Wells Fargo Securities, LLC are the joint bookrunning managers. SunTrust Robinson Humphrey, Inc., KeyBanc Capital Markets Inc., Avondale Partners, LLC and Piper Jaffray & Co. are the co-managers.

Proceeds will be used to repay debt and for general corporate purposes.

The Fort Meyers, Fla., company offers cancer treatment services.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.